Legal Representation
Attorney
Joshua S. Frick
USPTO Deadlines
Next Deadline
200 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
January 23, 2026
Extension Available
Until July 23, 2025
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 2, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jul 2, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 2, 2025 | EXT2 | S | SOU EXTENSION 2 FILED |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 23, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jan 23, 2025 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jan 23, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 23, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| May 28, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 28, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 8, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 25, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 19, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 19, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 19, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Dec 26, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Dec 26, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Dec 26, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 14, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 11, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 23, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Providing online non-downloadable computer software platforms for use by pharmaceutical manufacturers, distributors, pharmacies, other prescription drug supply chain trading partners, and regulators for obtaining and verifying data, including licensure and drug product identifying data, and facilitating data requests with each other to promote compliance with drug supply chain statutes and regulations
Additional Information
Pseudo Mark
PULSE BY NATIONAL ASSOCIATION OF BOARDS OF PHARMACY
Classification
International Classes
042